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ABSTRACT The control of protein synthesis
during maturation in oocytes is mainly exerted through
cytoplasmic polyadenylation of stored mRNAs. We first
analyzed the polyadenylation status of cyclins A2 and
B1 during in vitro maturation (IVM) of bovine oocytes,
using Rapid Amplification of cDNA Ends-Polyadenyla-
tion Technique (RACE-PAT). An inconstant elongation
of the poly(A) tail was observed for cyclin A2 trans-
cripts after maturation, while a constant lengthening
was observed for cyclin B1, occurring during the first
12 hr of incubation. We then evaluated the effects of
the polyadenylation inhibitor 30-deoxyadenosine (30-
dA), on polyadenylation and nuclear maturation. The
presence of 0.02 mM 30-dA during the whole incuba-
tion period or from 6 hr after its beginning completely
prevented meiosis progression in 100% of the oocytes.
Polyadenylation of cyclin B1 was also completely
prevented when 30-dA was added at 0 hr, and greatly
reduced when added at 6 hr. When 30-dA was added at
12 hr, around metaphase I (MI), 46.9% of the oocytes
have reached metaphase II (MII, vs. 78.8% in the
control group) at 24 hr. The use of the same con-
centration of 30-deoxyguanosine (30-dG), that impairs
transcription but not polyadenylation, did not affect
cyclins polyadenylation, nor nuclear maturation, what-
ever was the timing of addition. These results suggest
that the polyadenylation of cyclin B1 could be related
to the first peak of activity of MPF, occurring around MI
(10–12 hr after the onset of the maturation period).
They also show that, in our culture conditions, inhibi-
tion of polyadenylation prevents meiosis progression,
especially up to the MI stage, while inhibition of trans-
cription does not. Mol. Reprod. Dev. 71: 107–114,
2005.  2005 Wiley-Liss, Inc.
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INTRODUCTION
Mammalian oocytes are arrested in late G2 of the first
meiotic division, at the germinal vesicle (GV) stage.
Theseoocyteswill resumemeiosis, eithernaturally after
hormonal stimulation (LH surge), or if released from the
inhibitory influence of the follicular environment, as in
the case of in vitro cultures (Pincus andEnzmann, 1935;
Smith, 1989).
Events taking place during in vitro oocytematuration
can be distinguished as occurring at the nuclear or
cytoplasmic level. The first evident event of nuclear
maturation is chromatin condensation, followed by the
germinal vesicle breakdown (GVBD). Meiosis then
continues with completion of the first meiotic division,
extrusion of the first polar body, and the oocyte’s arrest
atmetaphase of the secondmeiotic division (MII). At the
cytoplasmic level, numerous mRNA molecules and
proteins are stored during the growth phase that
precedesmaturation. The stockpile ofmRNAswill allow
protein synthesis in the maturing oocyte and early
embryo while transcription is maintained at very low
levels, a period that in the bovine species spans from
GVBD up to the 9/16-cell stage embryo (Memili and
First, 1999, 2000). At the 9/16-cell stage, the embryo
genomebecomes fully functional and gene expressionno
longer dependsmostly on transcripts ofmaternal origin.
During this transcriptionally-almost-silent period,
gene expression control is exerted at the post-transcrip-
tional level mainly by cytoplasmic polyadenylation
(reviewed by Richter, 1999; de Moor and Richter, 2001;
Macdonald, 2001; Mangus et al., 2003). It has been
demonstrated that such control involves the action of
various factors on specific sequences found in the 30
untranslated region (30-UTR) of certain transcripts.
Amongst those sequences, the most important ones
are AAUAAA, known as nuclear polyadenylation ele-
ment (NPE), and the cytoplasmic polyadenylation
element (CPE), a UUUUUAU consensus motif that is
generally found immersed in aU-rich regionaround20–
30 nucleotides upstream of the NPE (Fox et al., 1989;
McGrew et al., 1989). Cytoplasmic polyadenylation
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allows a fine and precise control of the translation of
many of the mRNAs stored in the cytoplasm. Amongst
those mRNAs we can mention genes that play a key
role in the resumption and control of themeiotic process
or in pre-implantation development, as it has been
described for c-mos, cyclins, and cdks in Xenopus laevis
(Sheets et al., 1995; Stebbins-Boaz et al., 1996; de Moor
and Richter, 1997; Barkoff et al., 1998; reviewed by
Richter, 1999), and c-mos and cyclin B1 in mouse
(Gebauer et al., 1994; Gebauer and Richter, 1996; Tay
et al., 2000).
The meiotic process is mainly controlled by the
activities of both the mitogen activated protein kinase
(MAPK) and the maturation promoting factor (MPF).
MPF is a heterodimer formed between cyclin B1, which
is the regulatory component, and p34cdc2 kinase, also
known as cyclin-dependent kinase 1 (cdk1), which en-
closes the catalytic domain. MPF is the key regulator of
meiotic resumption in oocytes (Wasserman and Masui,
1976), and its activity is regulated by phosphorylation/
dephosphorylation in Thr-14 and Tyr-15 of cdk1, re-
spectively carried out by the wee1/Myt1 kinases and
the cdc25 phosphatase (reviewed by Morgan, 1995;
Yamashita et al., 2000). In thebovine species, theneedof
polyadenylation for MPF activation has been reported
(Krischek and Meinecke, 2002), as well as the relation-
ship between polyadenylation status and oocyte devel-
opmental competence, and its evolution between oocyte
maturation and first embryonic cleavage (Brevini-
Gandolfi et al., 1999; Brevini et al., 2002). Previous
work also showed the changes in the levels of cyclin B2
protein during oocyte maturation (Wu et al., 1997), and
the changes in the levels of cyclin B1 protein (Levesque
andSirard, 1996) andmRNA(Robert et al., 2002).Cyclin
A presents two subtypes in mammals, namely A1 and
A2. Cyclin A2 controls the progression through S phase
and the entry into M phase (Pagano et al., 1992; Loyer
et al., 1994), and is essential for development in mouse,
the null genotype being lethal, as it was proven in vivo
using a targeted deletion strategy against the A2 gene.
Nevertheless, embryos lacking the cyclin A2 gene can
developuntil the stage of implantation at aroundday5.5
post coitum (Murphy et al., 1997).
In the bovine species, the presence of cyclin A2mRNA
has recently been detected in immature and mature
oocytes, both in vitro and in vivo (Lonergan et al., 2003),
however, to our knowledge there is no information about
the polyadenylation status of cyclin A2 transcript in
bovine oocytes during in vitro maturation (IVM).
Oneof the goals of thisworkwas to analyze thepoly(A)
tail length of cyclins B1 and A2 during IVM in bovine
oocytes. For doing so, we used Rapid Amplification
of cDNA Ends-Poly(A) Test (RACE-PAT), a method
described by Salles and Strickland (1995); Salles et al.
(1999). This technique was chosen instead of oligo(dT)/
RNaseH-Northern, the classical polyadenylation assay,
as it is much more sensitive. We combined the RACE-
PAT analysis with the use of 30-deoxyadenosine (30-dA),
a strong inhibitor of polyadenylation, and 30-deoxygua-
nosine (30-dG) as a control. When 30-dA is added to the
maturationmedium, it ismetabolized in the oocyte to 30-
dATP, and incorporated into growing nucleotide chains
and poly(A) tails during polyadenylation. Once 30-dA is
added to the poly(A) tail, further addition of adenosine
is prevented because of the lack of a hydroxyl group
(Siev et al., 1969; Nakazato et al., 1974; Kuge and
Inoue, 1992). The use of 30-dG allowed us to discriminate
between polyadenylation inhibition (exerted by 30-dA)
and transcription inhibition (due to both 30-dA and
30-dG).
The impact of adenylation inhibition on nuclear
maturation was also analyzed, at different times during
the maturation period.
MATERIALS AND METHODS
Collection of Oocytes and IVM
Ovaries were collected at a local slaughterhouse
and transported to the laboratory at room temperature
(>208C). Cumulus-oocyte complexes (COCs) were aspi-
rated from follicles ranging from 3 to 8 mm in diameter,
and only good quality COCs (dark homogeneously
granulated cytoplasm surrounded by three or more
compact layers of cumulus cells) were selected. Groups
of 20–70 COCs were placed into four-well multidishes
(Nunc, Roskilde, Denmark) and matured under 20% O2
and 5% CO2 in tissue culture medium 199 (TCM-199;
Gibco, Paisley, Scotland), supplemented with 10 ng/ml
epidermal growth factor (EGF; Sigma, Steinheim,
Germany) and 0.4 mM pyruvate, without serum. COCs
werematured for the appropriate timedepending on the
experimental conditions.
RNA Extraction
COCs were carefully denuded by repeated pipetting
and washed three times in TCM-199. The absence of
remaining cumulus cells attached to the oocytes was
verified by Hoechst staining. Pools of 20 oocytes were
made for each sample, and stored at 808C in a mini-
mum volume of medium. Total RNA from each pool was
extracted in 100 ml of Tripur (RocheMolecular Biochem-
icals, Indianapolis, IN) following specifications of
the manufacturer, and 20 mg of glycogen (Glycoblue;
Ambion, Austin) added as a carrier. After precipitation
in isopropanol, samples were centrifugated at 12,000g
and pellets washed in ethanol 70%, vacuum-dried, and
resuspended in RNAse-free water.
Determination of Nuclear Maturation
Oocytes were denuded and rinsed as already describ-
ed, and fixed overnight in ethanol 96% on a microscope
slide to assess the nuclear maturation status. Fixed
oocytes were stained with 10 mg/ml of Hoechst 33342
(bisbenzimide; Calbiochem, Darmstadt, Germany)
diluted in 2.3% tri-sodium citrate buffer. Oocytes were
examined under a Nikon fluorescence microscope
(excitation wavelength: 330–380 nm, barrier filter at
420nm), and classified asmetapase II (MII, presentinga
metaphasic plate and a polar body), metaphase I (MI,
presenting a metaphasic plate, but no polar body), and
stages before MI.
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RACE-PAT
Changes in the poly(A) tail length were studied using
RACE-PAT, a modification of the RACE protocol.
Reverse Transcription (RT)
Total extracted RNA was reverse-transcribed as
described by Salles and Strickland (1995), with
minor modifications. Reactives were purchased
from Invitrogen (Carlsbad, NM), unless otherwise
specified.
Briefly, RNAwas denatured at 658C during 5min in a
final volume of 6 ml, with 1 ml (200 ng/ml) of oligo(dT)
anchor (50-GCGAGCTCCGCGGCCGCGT12-30), and
transferred to a water bath at 428C. Then 14 ml of a
mixture were added, containing 4 ml of 5 Super-
ScriptTMIII Rnase H reverse transcriptase buffer
(250 mM Tris-HCl, 375 mM KCl, 15 mM MgCl2), 1 ml
(40 U/ml) Rnase inhibitor (Amersham Pharmacia,
Uppsala, Sweden), 2 ml 0.1M DTT, 1 ml 10 mM dNTPs
(Roche, Mannheim, Germany), 2 ml (400 U) Super-
ScriptTMIII Rnase H RT, and 4 ml of RNase-free water.
Samples were reverse transcribed at 428C for 1 hr,
ending with a step of 15 min at 658C for enzyme
inactivation.
PCR Amplification
RT samples were PCR-amplified using the oligo(dT)-
anchor primer already described, and the following
primers at the 50 end: cyclin A2: 50-TCAACCCACCAGA-
GACACTA-30, and cyclin B1: 50-GGCTGTGGCAAAGG-
TGTAAC-30, at positions 1193 and 1389, respectively.
Both 50 primers hybridize in the 30UTR region of each
analyzed transcript. Sequences for both cyclins were
obtained from a NCBI database (accession numbers
X68321 and L26548 for cyclin A2 and B1, respectively).
The size of the amplified fragments from the upper
primer location to the beginning of the poly(A) tail,
length of the poly(A) tail varies upon conditions—is of
324 bp for cyclin A2, and 165 bp for cyclin B1. We have
also used another 50 primer for cyclin B1 (50-ACCT-
GGCAAAGAATGTGGTC-30), at position 1249. Reac-
tives were purchased from Qiagen (Leusden, The
Netherlands), unless otherwise specified.
One microliter of RT product was amplified in a
reaction mixture consisting of 2.5 ml of 10 PCR Buffer
(Tris-HCl, KCl(NH4)2SO4, 15 mM MgCl2), 5 ml of Q
solution, 0.5 ml of 10 mM dNTPs (Roche), 12.5 pmol of
oligo anchor primer, 12.5 pmol of each 50 primer, 1.5U of
HotStarTaqTM DNA polymerase, and 14.7 ml of sterile
water. PCRwas carried out in a programmable thermal
cycler (PTC-100, MJ Research, Inc., Watertown, MA),
in the following conditions: 15 sec at 958C (activation
of the enzyme), 30 sec at 938C (double strand de-
naturation temperature), 1 min at 598C (annealing
temperature), and 1 min at 728C (double strand
extension temperature), performing 31 cycles. Differ-
ences in the poly(A) tail length were observed as
smears of proportional different lengths in a 4% agarose
gel.
Experimental Design
Experiment 1: Assessment of the poly(A) tail
length and nuclear maturation status during
IVM
Assessment of poly(A) tail length before and after
maturation. COCs were matured during 24 hr as
described above, and the length of the poly(A) tail
analyzed in denuded oocytes byRACE-PAT before (0 hr)
and after maturation (24 hr). Groups of 25–30 denuded
oocytes were fixed in parallel at the end of the matura-
tion period, in order to assess their nuclear maturation
status. This experiment was carried out nine times for
cyclin A2 and five for cyclin B1.
Kinetics of the changes in the poly(A) tail for cyclin
B1, and assessment of nuclear maturation status
duringmaturation. With theaimof studying the timing
of the changes in the poly(A) tail during the meiotic
process, a kinetic study was carried out for cyclin B1.
Maturation was stopped at 6, 12, 18, and 24 hr from the
onset of the process, and the length of the poly(A) tail
analyzed by RACE-PAT in denuded oocytes. In parallel,
groups of 25–30 denuded oocytes were fixed for each
time point, and the nuclearmaturation status analyzed.
This experiment was repeated two times.
Experiment 2: Inhibition of polyadenylation
during IVM. Cordycepin (30-dA) and (30-dG)were used
as specific inhibitor of polyadenylation and control,
respectively. Both purines were purchased from Sigma
(Steinheim, Germany).
Effects of 30-dA on poly(A) tail length and nuclear
maturation status. In a preliminary experiment, dif-
ferent concentrations of 30-dA and 30-dG were tested, (2,
0.5, 0.08, 0.02, and 0.01 mM final concentration in the
maturation medium). The 0.02 mM concentration was
chosen, as it was the lower concentration of 30-dA that
effectively inhibited polyadenylation. 30-dG was used at
the same concentration (data not shown).
COCs were matured during 24 hr in the presence of
30-dA or 30-dG, and the length of the smear obtained by
RACE-PAT was analyzed in denuded immature (0 hr)
and mature (24 hr) oocytes. Oocytes issued from COCs
matured innormal conditions for the sameperiod of time
were used as control. Groups of 25–30 denuded oocytes
from each condition were fixed at the end of the matu-
ration period (24 hr), and the nuclearmaturation status
analyzed. The experiment was repeated three times.
Effects of the addition of 30-dA at different times
during maturation. Cyclin B1 poly(A) tail length and
nuclear maturation status. 30-dAor 30-dGwere added to
maturation medium at 0, 6, 12, and 18 hr from the
beginning of the incubation period, to assess the effects
of 30-dA addition on nuclear maturation and polyadeny-
lation, during the maturation process. The length of the
smear obtained byRACE-PATwas analyzed in denuded
oocytes at the end of maturation (24 hr). Groups of 25–
30 denuded oocytes for each time point were fixed at the
end of the maturation period (24 hr), and the nuclear
maturation status analyzed. The experiment was
repeated twice.
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Study of the reversibility of the effect of 30-dA on
nuclear maturation status. The aim of this experiment
was to test the reversibility of the action of cordycepin
on the prevention of meiosis resumption. COCs were
incubated in maturation media containing 30-dA or 30-
dG during 2, 4, and 6 hr, rinsed three times in TCM-199,
and transferred to normal maturation medium until
completing 24 hr of maturation. Groups of 25–30
denuded oocytes for each conditionwere fixed in parallel
at the end of the maturation period, and the nuclear
maturation status analyzed as already described. The
protocol was repeated three times.
RESULTS
Experiment 1: Assessment of the Poly(A)
Tail Length and Nuclear Maturation
Status During IVM
Assessment of poly(A) tail length before and
after maturation
Cyclin A2. Immature oocytes presented a very short
smear. Inconstant presence of a longer smear was
observed after 24 hr of maturation in roughly half (five
out of nine) of the samples (Fig. 1). Taking this into
account, cyclin A2 transcript was not further analyzed.
Cyclin B1. Immature oocytes present a short smear,
that appears lengthened after 24 hr of incubation in
the maturation medium (Fig. 2). Similar results
were obtained with the two different 50 primers used.
Representative results obtained with one of the primers
(50-GGCTGTGGCAAAGGTGTAAC-30) are shown.
Kinetics of the changes in the poly(A) tail for
cyclin B1, and assessment of nuclear maturation
status during maturation. An increase of the smear
length was already observed at 6 hr, and a further
increase was seen at 12 hr from the beginning of the
maturation period. No further changes in the smear
length were observed at 18 and 24 hr (Fig. 3).
Overall, an 80% maturation rate was observed after
24 hr incubation. A large majority of the oocytes had
reached the MII stage 18 hr after the beginning of the
maturation period (Table 1).
The MI stage was reached between 6 and 12 hr of
incubation.
Experiment 2: Inhibition
of Polyadenylation During IVM
Effects of 30-dA on poly(A) tail length and
nuclear maturation status. When oocytes were
matured during 24 hr in the presence of 0.02 mM
30-dA, no lengthening in the smear was observed at the
end of thematuration period, and transcripts presented
a smear of the same length as beforematuration or even
shorter.However, the group treatedwith 0.02mM30-dG
showeda smear of the same length of the one observed in
the control groupmatured in normal conditions (Fig. 4).
Moreover, 30-dA completely blocks meiosis progres-
sion in treated oocytes: none of the oocytes reached the
MI stage (n¼ 75). There were no significant differences
in the maturation status between 30-dG-treated (n¼64)
Fig. 1. RACE-PAT analysis in cyclin A2 transcript, before and after
maturation. MW: molecular weight marker (bp); I: immature oocytes;
M: mature oocytes.
Fig. 2. RACE-PAT analysis in cyclin B1 transcript, before and after
maturation. MW: molecular weight marker (bp); I: immature oocytes;
M: mature oocytes.
Fig. 3. RACE-PAT analysis in cyclin B1 transcript, kinetics of
maturation. MW: molecular weight marker (bp); 0–24: time (hr) from
the onset of the maturation period.
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and normally matured oocytes (n¼ 76): 70% and 83%
MII for 30-dG and normally matured, respectively
(X2: P> 0.05).
Effects of the addition of 30-dA at different
times during maturation. Cyclin B1 poly(A) tail
length and nuclear maturation status. Adding 30-
dA to the incubation medium from 12 hr or 18 hr after
the onset of the maturation period, resulted in oocytes
showing at 24 hr a smear length similar to control
oocytes matured during 24 hr in normal conditions.
However, when 30-dA was incorporated from 6 hr of the
beginning of the maturation period, an important
shortening of the smear lengthwas observed. The smear
length equaled that of immature oocyteswhen30-dAwas
added at the onset of the culture period (Fig. 5).
Concerning nuclear maturation, none of the oocytes
maturedwhen 30-dAwas added at 6 hr. Addition of 30-dA
at 12 hr blocked half of the oocytes atMI stage or before,
the remaining half reaching the MII stage at the end of
the maturation period. As most of the oocytes had
already reached the MII stage by 18 hr in our culture
conditions, the addition of 30-dA at 18 hr had no effect on
the rate of MII observed at 24 hr. Once more, 30-dG
addition did not affect the smear length or the nuclear
maturation rates in any of the groups observed (Fig. 6).
Study of the reversibility of the effect of 30-dA
on nuclear maturation status. In the conditions
used in this study, adding 30-dA during the first 4 or 6 hr
of maturation prevented oocyte maturation to the same
extent as 24 hr treatment with the same inhibitor.
However, the addition of the polyadenylation inhibitor
during the first 2 hr of maturation, allowed 21% of the
oocytes to reach MII stage (Table 2).
DISCUSSION
For the first time, the polyadenylation status of cyclin
A2 and B1 mRNA was evaluated during IVM of bovine
oocytes using RACE-PAT analysis.
Two sensitive PCR-based techniques allow to study
the length of the poly(A) tail of specific transcripts:
RACE-PAT, which we used in this work, and the ligase-
mediated polyadenylation technique (LM-PAT). LM-
PAT allows a more precise quantification of the poly(A)
tail length, and was previously used to study the
polyadenylation status of transcripts related to devel-
opmental competence in bovine oocytes (Brevini-Gan-
dolfi et al., 1999; Brevini et al., 2002). Despite several
TABLE 1. Kinetics of Nuclear Maturation of In Vitro
Matured COCs
Time (hr) N <MI(%) MI(%) MII(%)
6a 45 97.8 2.2 0
12b 55 23.6 76.4 0
18c 50 2.0 34.0 64.0
24c 47 2.1 19.1 78.8
Conditions with different superscripts differ significantly
(contingency table—P< 0.001). <MI, stages previous to meta-
phase I; MI, metaphase I; MII, metaphase II. Incubation was
stoppedandoocytesfixedandanalyzedat thegiven times (inhr
from the onset of the incubation period).
Fig. 4. RACE-PAT analysis of polyadenylation inhibition in cyclin
B1 transcript, before and after maturation. MW: molecular weight
marker (bp); I: immature oocytes; M: mature oocytes; dA: 0.02 mM 30-
dA-treated oocytes; dG: 0.02 mM 30-dG-treated oocytes.
Fig. 5. RACE-PAT analysis in cyclin B1 transcript, kinetics of
polyadenylation inhibition. MW: molecular weight marker (bp); dA:
0.02 mM 30-dA-treated oocytes; dG: 0.02 mM 30-dG-treated oocytes.
Numbers indicate the time (in hours from the onset of the incubation) of
addition of either 30-dA or dG. PCR analysis was done at 24 hr for all
treatments.
Fig. 6. Nuclear maturation kinetics in the presence of 30-dA. CTRL:
control; dA: 0.02 mM 30-dA-treated oocytes; dG: 0.02mM 30-dG-treated
oocytes. Numbers indicate the time (in hours from the onset of the
incubation) of addition of either 30-dA or dG. Data with different
superscripts are significantly different between groups (contingency
table—P< 0.001).
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essays, we did not succeed to obtain reproducible results
using LM-PAT for cyclin A2 and B1 transcripts. A
similar situation was reported by Fuchimoto et al.
(2001), working with A1 and A2 cyclins in mouse
oocytes.
Regarding cyclin A2 mRNA, an elongation of the
smear was observed inconstantly within the different
samples analyzed, which prevented us to study further
the polyadenylation kinetics of this transcript. These
variations could be due to the location of the 50 primer
used in the PCR amplification, which is not located
as close to the poly(A) tail as it would be desirable to
allow an easy detection of variations in the size of the
amplicons. Unfortunately, due to the characteristics of
the cyclin A2 sequence in the 30 UTR, we did not succeed
in finding better primers. Our results thus indicate that
cyclin A2 transcripts are present in the bovine oocyte,
but it is not clear whether their translation is regulated
by cytoplasmic polyadenylation during IVM. This is
in agreement with the results obtained in the mouse
oocytes, where cyclin A2 transcripts are present at the
GV stage, but the protein is only detected after ferti-
lization (Fuchimoto et al., 2001). The expression of
the protein in the mouse embryo is not related to the
quantity of the mRNA (the highest levels of cyclin A2
mRNA are indeed observed at the GV stage), but to an
increase in the size of the transcript observed after
fertilization (Fuchimoto et al., 2001); and prevented by
adding 30-dA shortly after fertilization, which suggests
that polyadenylation of the transcript plays a key role in
the translation into the protein involved in the first
mitosis. Thisperiod of early embryonicdevelopmentwas
not the object of our study focused on bovine oocytes, but
it could be interesting to evaluate in a further study the
polyadenylation of cyclin A2 mRNA in the bovine
embryo where, unlike the mouse, the major onset of
the embryonic genome is not coincident with the first
mitosis.
An important increase in the length of the smear
was observed for cyclin B1 mRNA using two different
primers. Such increase was associated with the length-
ening of the poly(A)tail of the transcript during IVM as
it disappeared in presence of 30-dA, an inhibitor of
polyadenylation. It has been suggested that cyclin B1
synthesis plays a key role in meiotic resumption in
bovine oocytes. Indeed, Levesque and Sirard (1996)
demonstrated that, in this species, the injection of cyclin
B1 was sufficient to trigger meiosis resumption in the
presence of an inhibitor of protein synthesis. As sum-
marized in the Introduction, cyclin B1 is one of the two
components of the MPF. MPF presents two peaks of
activity during oocyte nuclear maturation in verte-
brates: the first one slightly preceding or coincidentwith
MI, and the second with MII, with a temporary drop
during the transition between MI and MII (reviewed
by Nebreda and Ferby, 2000). This MPF activity pat-
tern was also reported in the bovine by Wehrend and
Meinecke (2001), Wu et al. (1997), and Fissore et al.
(1996). Results obtained in the present work, allows us
to postulate that cyclin B1 mRNA undergoes cytoplas-
mic polyadenylation between 0 and 12 hr of maturation,
and to a greater extent between 6 and 12 hr. This
polyadenylation takes place in parallel with MPF
activity, which starts around GVBD, and peaks around
MI. In our culture conditions, most of the oocytes are in
MI at 12 hr, and the poly(A) tail had also reached its
maximal length by then. We can speculate that this
poly(A) tail elongation would lead to a translation of the
mRNA into cyclin B1 protein, accounting for the first
peak in MPF activity in this species. In a short
communication, Tremblay et al. (2004) showed some
polyadenylation of bovine cyclinB1 already taking place
before IVM, if the ovaries were transported and
manipulated in warm saline. This polyadenylation was
avoided if the transport and manipulation was per-
formed on ice. Such changes in polyadenylation before
the maturation period were not evaluated in this study.
Interestingly, the study by Tomek et al. (2002) in
bovine oocytes reported that, if the incorporation of A
residues was important between 2 and 6 hr, a further
increase in incorporation took place between 6 and 10 hr
ofmaturation, when a drop in transcription activity was
observed. This last observation strongly suggests that A
residues are used for an intense polyadenylation process
andnot for transcription,which is inagreementwith our
results showing a major impact of polyadenylation
inhibition at that time. Moreover, in this work, none of
the oocytes reached theMI phasewhen polyadenylation
was prevented by 30-dA during the whole maturation
period. Adding 30-dA at 6 hr after the onset of the
maturation period (around the GVBD stage), also
completely blocked meiotic progression, while addition
from12hr prevented only 30%of the oocytes to reach the
MII stage. The fact that adding 30-dA at 12 hr, around
the MI stage, impaired nuclear maturation in only 30%
of the oocytes suggested that polyadenylation processes
are less critical for the transition between MI and MII
than between GVBD andMI. Inhibition of polyadenyla-
tion from the MI stage had no impact on the poly-
adenylation of cyclin B1, and other target transcripts
playing a role at later stages of nuclear maturation, are
thus to be identified.
TABLE 2. Test of Reversibility for the Action of 30-dA
Treatment N <MI(%) MI(%) MII(%)
Controla 56 0 19 81
dA 24 hrb 54 100 0 0
dG 24 hra 49 0 16 84
dA 2 hrc 47 32 47 21
dG 2 hra 54 5 15 80
dA 4 hrb 50 96 0 4
dG 4 hra 57 7 18 75
dA 6 hrb 59 100 0 0
dG 6 hra 41 7 15 78
Data with different superscripts are significantly different
(contingency table—P< 0.001). <MI, stages previous to meta-
phase I; MI, metaphase I; MII, metaphase II. Time in hr
indicates the period of incubation with 30-dA/dG, before
washing and completing 24 hr of incubation in normal
maturation conditions.
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The link between polyadenylation and the capacity to
undergo nuclear maturation is further confirmed by the
results obtained with the use of 30-dG.When this purine
analog was added to the maturation medium, neither
polyadenylation nor nuclear maturation was affected,
regardless of the duration, timing of addition or
concentrations used (data not shown). This indicates
that the inhibition of transcription arising from the use
of this modified purine had no impact on nuclear
maturation and that the effects observed using 30-dA
are clearly due to the inhibition of polyadenylation and
not to transcription impairment that should occur with
both purine analogs. Confirming evidence can be found
in previous works (Farin and Yang, 1994; de Wit and
Kruip, 2001; reviewed by Rodriguez and Farin, 2004),
showing that bovine COCs are able to resume meiosis
in vitro in the presence of transcription inhibitors, when
FSH is not used in the maturation protocol.
The incubation with 0.02 mM 30-dA added to the
maturation medium at 6 hr or before led to an irrever-
sible inhibition of meiosis resumption in all the oocytes.
If 30dA was added during the first 2 hr of culture, an
important drop in the maturation rate was observed
after rinsing and restoring normal culture conditions.
Nevertheless, 20% of the oocytes reached MII, and
almost 50% reachedMI, showing that the inhibitionwas
not always irreversible. The permanent effects observed
could be due to the importance of the processes being
affected by the action of 30-dA at the beginning of the
maturation period, likeGVBD, andnot necessarily to an
irreversibility of the inhibition. Indeed, the reversibility
of theactionof 30-dAhasbeenextensively reported in the
literature in somatic cells, as well as in Xenopus oocytes
(Kuge and Inoue, 1992).
CONCLUSIONS
The variations in the polyadenylation status of cyclins
A2 and B1 were studied for the first time during IVM in
bovine oocytes. Inparallel, the effects of polyadenylation
inhibition on meiosis progression were also analyzed.
We reported a poly(A) tail elongation for cyclin B1
transcript occurring during the first 12 hr of IVM in
bovine oocytes, which could account, at least partly, for
the first MPF activity peak observed at the time of MI.
Inhibition of polyadenylation and transcription pre-
vented meiotic progression, especially when polyadeny-
lation was blocked between GVBD andMI stages, while
impairment of transcription alone never did.
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